➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Dow
McKesson
McKinsey
Baxter

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Quazepam - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for quazepam and what is the scope of freedom to operate?

Quazepam is the generic ingredient in one branded drug marketed by Galt Pharms and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for quazepam. One supplier is listed for this compound.

Summary for quazepam
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 17
Clinical Trials: 1
Patent Applications: 5,775
What excipients (inactive ingredients) are in quazepam?quazepam excipients list
DailyMed Link:quazepam at DailyMed
Recent Clinical Trials for quazepam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Saint-Joseph UniversityPhase 3

See all quazepam clinical trials

Pharmacology for quazepam
Drug ClassBenzodiazepine
Anatomical Therapeutic Chemical (ATC) Classes for quazepam

US Patents and Regulatory Information for quazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for quazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galt Pharms DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 ⤷  Free Forever Trial ⤷  Free Forever Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ⤷  Free Forever Trial ⤷  Free Forever Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ⤷  Free Forever Trial ⤷  Free Forever Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Dow
McKesson
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.